Importance Women with ductal carcinoma in situ (DCIS), or stage 0 breast cancer, often
experience a second primary breast cancer (DCIS or invasive), and some ultimately die of …

Importance It is not clear to what extent a diagnosis of ductal carcinoma in situ (DCIS)
impacts a woman's lifetime risk of dying of breast cancer. Under ideal circumstances …

Background The vast majority of women diagnosed with ductal carcinoma in situ (DCIS)
undergo treatment. Therefore, the risks of invasive progression and competing death in the …

Objective: To assess cause-specific mortality in women treated for ductal carcinoma in situ
(DCIS). Background: From screening and treatment perspective, it is relevant to weigh the …

Background Over 14% of breast cancers diagnosed in the United States annually are ductal
carcinomas in situ (DCIS). There are no published population-based reports of the likelihood …

Purpose To assess the effect of different treatment strategies on the risk of subsequent
invasive breast cancer (IBC) in women diagnosed with ductal carcinoma in situ (DCIS) …

Background: Ductal carcinoma in situ (DCIS) accounts for approximately 12% of newly
diagnosed breast cancers. Knowledge of the factors that predict who will be diagnosed with …

We performed a systematic review with meta-analyses to summarize current knowledge on
prognostic factors for invasive disease after a diagnosis of ductal carcinoma in situ (DCIS) …

Background Management of screen-detected ductal carcinoma in situ (DCIS) remains
controversial. Methods A prospective cohort of patients with DCIS diagnosed through the UK …

Objective To evaluate the long term risks of invasive breast cancer and death from breast
cancer after ductal carcinoma in situ (DCIS) diagnosed through breast screening. Design …